Contact this trialFirst, we need to learn more about you.
Bruton's Tyrosine Kinase (BTK) Inhibitor
Tolebrutinib for Multiple Sclerosis
Recruiting1 awardPhase 3
Knoxville, Tennessee
This trial is studying the long-term safety and tolerability of a drug called tolebrutinib in adults with certain types of multiple sclerosis. Participants in this trial were previously enrolled in other studies
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.